Thursday, January 27, 2022


Pfizer, CornoaVac vax linked to heart inflammation risk in adolescents

Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis -- a type of heart inflammation -- associated with Covid...

Covid booster dose provides good antibody protection against Omicron: Lancet

London: A third 'booster' dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings. Published as a research...

Pfizer’s Covid pill effective against Omicron variant

Washington: Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its...

Pfizer vaccine 40 times less effective against Omicron: South African study

Johannesburg: Pfizer's mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study...

Editorial: End vaccine inequality

The global fears over the emergence of Omicron, the new and more virulent coronavirus variant, once again highlight an often neglected aspect of the...

US reopens to foreign travellers from November 8

Hyderabad: The Biden administration has announced revised international air travel rules for those flying to the United States, with the rules to come into...

Pfizer, Moderna vaccines cut COVID-19 risk by 91 per cent: Study

The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.

Pfizer, Moderna Covid shots generate lasting immunity

Even 15 weeks after the first dose, eight of 10 people still had detectable germinal centers containing B cells targeting the virus.

Pfizer, Moderna COVID-19 vaccines don’t lower sperm count, study says

The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.

UK approves Pfizer/BioNTech COVID shot for 12-15 year-olds

The Pfizer/BioNTech COVID-19 vaccine is already approved for use in adults and adolescents aged 16 years and above.

Editorial: Review vaccination policy

The Centre should consider utilising its position as the monopolistic buyer in the market and pass down the benefit to all people

Vaccine for children stirs up debate

Experts say hospitalisation, mortality likely to rise among the age group

Visa dates, vaccinations and the path ahead

It is imperative to note that while every university has different rules, we expect many of them will require students to be vaccinated to participate in on-campus study

Acquiring vaccine to be tough task for States

Anticipating the shortages, many States including Telangana had recently gone for global tenders

Editorial: Flawed vaccination policy

States like Telangana opting for global tenders to procure vaccine is a pragmatic decision, given the Centre's opaque policy

Latest News

- Advertisement -